Robotic Next Generation Sequencing Platform Accurately Screens Thousands of COVID-19 Samples at Once
|
By HospiMedica International staff writers Posted on 04 Mar 2021 |
|
Image: Jeff Wrana, left, is seen in this undated file photo at the Lunenfeld-Tanenbaum Research Institute in Toronto, Canada (Photo courtesy of Sinai Health)
A robotics platform to screen thousands of COVID-19 samples at once has the potential to revolutionize how labs track the spread of viruses and other pathogens, according to new findings.
The study by researchers from the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health (Toronto, ON, Canada) found that their next-generation, ultra-high-throughput sequencing platform, called C19-SPAR-Se, has a sensitivity rate greater than 95% in positive cases during peak onset. The platform is also cost-effective. The study notes it only costs about USD 8 per test when running thousands of samples at once, as the cost per sample decreases due to economies of scale.
"Identifying positive samples quickly and accurately is critical in beating this pandemic," said Dr. Jeff Wrana, senior investigator at the LTRI and professor in the Department of Molecular Genetics at the University of Toronto. "With new and potentially dangerous variants now circulating, this is a platform that is scalable, automated and capable of analyzing thousands of COVID-19 patient samples in a single instrument run."
Related Links:
Lunenfeld-Tanenbaum Research Institute
The study by researchers from the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health (Toronto, ON, Canada) found that their next-generation, ultra-high-throughput sequencing platform, called C19-SPAR-Se, has a sensitivity rate greater than 95% in positive cases during peak onset. The platform is also cost-effective. The study notes it only costs about USD 8 per test when running thousands of samples at once, as the cost per sample decreases due to economies of scale.
"Identifying positive samples quickly and accurately is critical in beating this pandemic," said Dr. Jeff Wrana, senior investigator at the LTRI and professor in the Department of Molecular Genetics at the University of Toronto. "With new and potentially dangerous variants now circulating, this is a platform that is scalable, automated and capable of analyzing thousands of COVID-19 patient samples in a single instrument run."
Related Links:
Lunenfeld-Tanenbaum Research Institute
Gold Member
12-Channel ECG
CM1200B
Patient Monitoring System
AlarmSense
Monitor/Defibrillator
Zenix
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
AI Tool Predicts Post-Heart Attack Trajectories to Personalize Follow-Up
Acute myocardial infarction (heart attack) survivors often develop new comorbidities and complications that unfold over years. Predicting which patients will deteriorate and where problems will arise remains... Read more
AI Digital Twin Platform Supports Personalized Cancer Treatment
Oncology teams face persistent challenges in tailoring treatment plans as tumors evolve and responses vary across patients. Static snapshots from imaging or genomics offer limited guidance for complex... Read more
Study Reveals Persistent Race and Gender Bias in Medical AI Models
Hospitals are turning to artificial intelligence (AI) to draft clinical materials and support decision-making, yet algorithmic bias can entrench inequities in care. When generated content reflects racial... Read more
New Study Highlights Benefits and Risks of AI Explanations in Clinical Diagnosis
Explainable artificial intelligence is increasingly used in tools that help clinicians and patients assess skin disease, but its explanations can influence decisions and contribute to overreliance or error.... Read moreCritical Care
view channel
Contactless AI Tool Detects Hypertension and Diabetes from Facial Video
Hypertension and diabetes are widespread yet often undiagnosed, driving preventable cardiovascular morbidity and mortality. Screening typically depends on clinic visits or wearable devices, which can limit... Read more
AI Tool Predicts Bladder Cancer from Electronic Health Records
Bladder cancer causes substantial mortality and is often detected late because early symptoms can resemble benign urologic conditions. Reliance on visible hematuria and confirmatory cystoscopy may delay... Read more
Surgical Techniques
view channel
Robot-Assisted Surgery Shows Advantages Over Laparoscopy in Gastric Cancer
Gastric cancer is most often treated with surgery, yet minimally invasive techniques can be technically challenging. Laparoscopic gastrectomy reduces recovery time compared with open surgery but relies... Read more
New Implant-Based System Gains FDA Approval for GERD Treatment
Gastroesophageal reflux disease is often treated surgically with techniques that encircle the esophagus, a strategy associated with dysphagia, inability to belch or vomit, and gas bloating.... Read more
Patient Care
view channel
Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
Emergency department (ED) boarding—the practice of keeping admitted patients in the ED while awaiting an inpatient bed—creates hazardous delays in definitive care. Prolonged transitions expose older and... Read more
Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
Fluoroscopy-guided procedures expose clinicians to scatter radiation that accumulates over time, creating persistent occupational risks in cath labs and interventional suites. Traditional badges typically... Read more
Medical Imaging
view channel
Study Links Thymus Radiation Dose to Poorer Outcomes in Lung Cancer
Collateral radiation to the thymus during therapy for non-small cell lung cancer (NSCLC) may compromise antitumor immunity and disease control. The thymus is a small immune organ in the upper chest that... Read more
Automated AI Tool Enables Uncertainty-Aware Meningioma Volume Tracking on MRI
Magnetic resonance imaging (MRI) guides diagnosis and monitoring in brain tumors, yet routine measurements often rely on subjective reads or simplified two-dimensional calculations. These methods can miss... Read more
Health IT
view channel
Imaging Tool Quantifies Calcinosis Cutis Volume to Monitor Treatment
Calcinosis cutis involves calcium deposits in the skin or soft tissues that can develop anywhere in the body, causing pain, impaired mobility, and disability. Lesions along the spine or buttocks can make... Read more
Digital Symptom Monitoring Supports More Personalized Breast Cancer Care
Metastatic breast cancer, in which tumors spread to other organs, is incurable but increasingly managed with modern systemic therapies. As more treatments shift from hospital infusions to oral or at-home... Read more
Point of Care
view channel
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
Point-of-care imaging often depends on bulky optical systems that have difficulty visualizing nearly transparent cells and tissues without staining. These limitations can slow diagnosis and restrict use... Read more
Business
view channel
FDA Seeks Feedback on Regulating Generative AI Medical Devices
Generative artificial intelligence (AI) is rapidly entering clinical workflows, offering tools that could enhance patient care while introducing risks that differ from those of traditional software.... Read more
